These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
997 related items for PubMed ID: 18978503
1. Acetyl-L-carnitine in the management of pain during methadone withdrawal syndrome. Janiri L, Martinotti G, Tonioni F, Ghelardini C, Nicolai R, Galeotti N, Mosconi L, Calvani M, Bartolini A, Iannoni E. Clin Neuropharmacol; 2009; 32(1):35-40. PubMed ID: 18978503 [Abstract] [Full Text] [Related]
2. Opioid addicts at admission vs. slow-release oral morphine, methadone, and sublingual buprenorphine maintenance treatment participants. Giacomuzzi S, Kemmler G, Ertl M, Riemer Y. Subst Use Misuse; 2006; 41(2):223-44. PubMed ID: 16393744 [Abstract] [Full Text] [Related]
3. Effect of acetyl-L-carnitine in the treatment of painful peripheral neuropathies in HIV+ patients. Scarpini E, Sacilotto G, Baron P, Cusini M, Scarlato G. J Peripher Nerv Syst; 1997; 2(3):250-2. PubMed ID: 10975731 [Abstract] [Full Text] [Related]
4. Influence of the dose on the severity of opiate withdrawal symptoms during methadone detoxification. Glasper A, Gossop M, de Wet C, Reed L, Bearn J. Pharmacology; 2008; 81(2):92-6. PubMed ID: 17952010 [Abstract] [Full Text] [Related]
11. Detoxification of opiate addicts with multiple drug abuse: a comparison of buprenorphine vs. methadone. Seifert J, Metzner C, Paetzold W, Borsutzky M, Passie T, Rollnik J, Wiese B, Emrich HM, Schneider U. Pharmacopsychiatry; 2002 Sep; 35(5):159-64. PubMed ID: 12237786 [Abstract] [Full Text] [Related]
12. Slow-release oral morphine for maintenance treatment of opioid addicts intolerant to methadone or with inadequate withdrawal suppression. Kastelic A, Dubajic G, Strbad E. Addiction; 2008 Nov; 103(11):1837-46. PubMed ID: 19032534 [Abstract] [Full Text] [Related]
13. Dose ratio between morphine and methadone in patients with cancer pain: a retrospective study. Lawlor PG, Turner KS, Hanson J, Bruera ED. Cancer; 1998 Mar 15; 82(6):1167-73. PubMed ID: 9506365 [Abstract] [Full Text] [Related]
14. High-dose methadone produces superior opioid blockade and comparable withdrawal suppression to lower doses in opioid-dependent humans. Donny EC, Walsh SL, Bigelow GE, Eissenberg T, Stitzer ML. Psychopharmacology (Berl); 2002 May 15; 161(2):202-12. PubMed ID: 11981600 [Abstract] [Full Text] [Related]
18. Oxymorphone extended release for the treatment of chronic low back pain: a retrospective pooled analysis of enriched-enrollment clinical trial data stratified according to age, sex, and prior opioid use. Peniston JH, Gould E. Clin Ther; 2009 Feb 15; 31(2):347-59. PubMed ID: 19302907 [Abstract] [Full Text] [Related]
19. Antinociceptive effects of high-dose remifentanil in male methadone-maintained patients. Hay JL, White JM, Bochner F, Somogyi AA. Eur J Pain; 2008 Oct 15; 12(7):926-33. PubMed ID: 18262451 [Abstract] [Full Text] [Related]
20. Comparison of buprenorphine and methadone in the treatment of opiate withdrawal: possible advantages of buprenorphine for the treatment of opiate-benzodiazepine codependent patients? Reed LJ, Glasper A, de Wet CJ, Bearn J, Gossop M. J Clin Psychopharmacol; 2007 Apr 15; 27(2):188-92. PubMed ID: 17414244 [Abstract] [Full Text] [Related] Page: [Next] [New Search]